Dear COVID-19 Vaccination Program Provider:

This message is being sent to all COVID-19 Vaccination Program enrolled providers in an effort to increase vaccinated individuals’ ability to obtain an Excelsior Pass.  If you have not yet administered COVID-19 vaccine, you may disregard this message.

Excelsior Pass mobile application is New York State’s voluntary and secure way to retrieve and present digital proof of COVID-19 vaccination or negative COVID-19 test results. In order for users to retrieve the vaccination pass, their vaccination data within NYSIIS/CIR must be correct and up-to-date. Providers are responsible for entering all vaccination data and remediating any data errors for users who report difficulty in retrieving their pass. For more information on what to look for and how to fix data errors, please review this factsheet.

Some vaccinated individuals have been reporting difficulty obtaining their Excelsior Pass.  Beginning this week, an e-mail will be sent to these individuals directing them to review their vaccination record with their provider.  The e-mail will direct individuals to their vaccination provider by giving them the provider’s primary and secondary points of contact and contact information as it was submitted on the provider’s COVID-19 Vaccination Program enrollment form, unless updated information has been submitted by the provider entity.

If the contact information is outdated or there is a better point of contact who can assist vaccinated individuals with review and correction of their vaccination record, please submit updated information

Thank you for your participation in the COVID-19 Vaccination Program.


The NYS COVID-19 Vaccine Team

Categories: Covid ResourcesPublished On: July 11th, 2021Tags: , ,


Related Posts

  • FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age – December 9, 2022   Dear COVID-19 Vaccination Provider: On December 8, 2022, FDA authorized the bivalent Moderna COVID-19 vaccine for children ages 6 months through 5 years of age and bivalent Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4 […]

  • Yesterday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups: CDC’s Director Dr. Rochelle Walensky released a statement and signed a decision memo recommending updated (bivalent) COVID-19 boosters for children five years and older. This expands on CDC's recommendation issued September 1, 2022, for updated COVID-19 boosters of people ages 12 and older.

  • Updated Clinical Guidance For Individuals 6 Months-11 Years Old – June 22, 2022   Dear NYS COVID-19 Vaccine Provider: Effective June 18, 2022, the CDC has recommended that everyone ages 6 months and older in the United States should receive a COVID-19 primary series vaccination for the prevention of COVID-19. This attached provider guidance has […]

  • Updated Guidance for The New York State COVID-19 Vaccination Program for Individuals 12 Years of Age or Older June 13, 2022   Note: This guidance document applies specifically to health care providers offering COVID-19 vaccinations to adolescents and adults ages 12 and older. Guidance specific to COVID-19 vaccination of children ages 5-11 can be found […]